[Temporary Announcement] China Health Bridge: Announcement of Resolutions of the First Meeting of the Third Workers’ Congress

Announcement number: 2026-055

Securities code: 874239 Securities abbreviation: China Health Bridge Sponsoring broker: Shengang Securities

China Health Bridge Pharmaceutical Group Co., Ltd.

Announcement of Resolutions of the First Meeting of the Third Workers’ Congress

The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.

1. Meeting convening and attendance

(1) Meeting status

1. Meeting time: August 21, 2026

2. Meeting place: Conference room on the third floor of the first phase office area of Guangzhou International Bio-Island Standard Industrial Unit 3. Meeting method: On-site and communication method

3. Method of issuing meeting notice: written notice.

4. Conference host: Yan Fukang

5. Explanation on the legality and compliance of the convening situation:

The convening and convening procedures of this workers' congress complied with the provisions of the "Company Law of the People's Republic of China" and the "Articles of Association of China Health Bridge Pharmaceutical Group Co., Ltd.", and the resolutions of the meeting were legal and valid.

(2) Meeting attendance

The meeting should be attended by 50 employee representatives, and 40 employee representatives should be present and authorized to attend.

2. Proposal review status

(1) Consideration and approval of the "Proposal on the Election of Employee Representative Directors of the Company"

1. Contents of the motion:

In view of the fact that the term of the company’s second board of directors is about to expire, in accordance with the Company Law of the People’s Republic of China and the

Announcement number: 2026-055

According to the Articles of Association of China Health Bridge Pharmaceutical Group Co., Ltd., the Implementation Rules of the Employees’ Congress of China Health Bridge Pharmaceutical Group Co., Ltd., and other relevant provisions, Mr. Chen Hongping was elected as the employee representative director of the company’s third board of directors after being elected by the employees’ congress. His term of office shall be from the date when the third board of directors is reviewed and approved by the shareholders’ meeting to the expiration of the term of the third board of directors.

2. The voting results are as follows:

Voting results: Agree: 40 votes; oppose: 0 votes; abstain: 0 votes.

3. Avoidance of voting:

None.

4. Submit the voting status of the shareholders’ meeting:

This proposal does not need to be submitted to the shareholders' meeting for review.

3. Documents for reference

"Resolution of the First Meeting of the Third Workers' Congress of China Health Bridge Pharmaceutical Group Co., Ltd."

Board of Directors of China Health Bridge Pharmaceutical Group Co., Ltd.

August 24, 2026